Polkadot / HarryPotterTrumpSonic100Inu

BUNDS: Heavy suppply and Fed Powell are in focus Today

11 Feb 2025 02:26:22 By Buzz FX

US unemployment rate dips to 4.0% in January 2025, BLS finds

11 Feb 2025 02:26:22 By Buzz FX

Andlauer Healthcare Group (TSE:AND) Trading Up 0.5% - Still a Buy?

11 Feb 2025 02:26:11 By Buzz FX

American Lithium (OTCMKTS:LIACF) Trading Down 0.6% - What's Next?

11 Feb 2025 02:26:11 By Buzz FX

Metalla Royalty & Streaming (CVE:MTA) Trading 1.5% Higher - Still a Buy?

11 Feb 2025 02:26:11 By Buzz FX

BOE: Mann confirms she may not vote for a long succession of rate cuts

11 Feb 2025 02:21:22 By Buzz FX

UK Retail Sales Grew 2.6% Year-On-Year In January 2025, Study Finds

11 Feb 2025 02:20:23 By Buzz FX

US Dollar Forecast: Fed Testimony Set to Drive Volatility - GBP/USD and EUR/USD Outlook

11 Feb 2025 02:20:17 By Buzz FX

Digitisation does not mean deregulation: CEA Nageswaran - The Economic Times

11 Feb 2025 02:16:22 By Buzz FX

Citigroup Issues Pessimistic Forecast for Peloton Interactive (NASDAQ:PTON) Stock Price

11 Feb 2025 02:16:10 By Buzz FX

Analysts Set Devon Energy Co. (NYSE:DVN) Target Price at $49.45

11 Feb 2025 02:16:10 By Buzz FX

Oppenheimer Reiterates Market Perform Rating for Pliant Therapeutics (NASDAQ:PLRX)

11 Feb 2025 02:16:10 By Buzz FX

Piper Sandler Reaffirms Overweight Rating for Semtech (NASDAQ:SMTC)

11 Feb 2025 02:16:10 By Buzz FX

Needham & Company LLC Has Lowered Expectations for Pliant Therapeutics (NASDAQ:PLRX) Stock Price

11 Feb 2025 02:16:10 By Buzz FX

Stifel Nicolaus Cuts Tesla (NASDAQ:TSLA) Price Target to $474.00

11 Feb 2025 02:16:10 By Buzz FX

Illumina (NASDAQ:ILMN) Stock Rating Lowered by Barclays

11 Feb 2025 02:16:10 By Buzz FX

Needham & Company LLC Has Lowered Expectations for Semtech (NASDAQ:SMTC) Stock Price

11 Feb 2025 02:16:10 By Buzz FX

Robert W. Baird Cuts Crocs (NASDAQ:CROX) Price Target to $150.00

11 Feb 2025 02:16:10 By Buzz FX

Tesla (NASDAQ:TSLA) Given Hold Rating at Needham & Company LLC

11 Feb 2025 02:16:10 By Buzz FX

Pliant Therapeutics (NASDAQ:PLRX) Receives Hold Rating from Canaccord Genuity Group

11 Feb 2025 02:15:10 By Buzz FX